Full Name
Yeow Tee Goh
Goh, Y.T.


Results 1-11 of 11 (Search time: 0.009 seconds).

Issue DateTitleAuthor(s)
13-Sep-2021A phase 2 study of carfilzomib, cyclophosphamide and dexamethasone as frontline treatment for transplant-eligible MM with high-risk features (SGH-MM1)Chen, Yunxin ; Gopalakrishnan, Sathish Kumar; Ooi, Melissa ; Sultana, Rehena ; Lim, Li Hui; Grigoropoulos, Nicholas ; Ong, Shin Yeu ; Xu, Mingge; Chng, Wee Joo ; Goh, Yeow Tee ; Nagarajan, Chandramouli
22017Clinicopathological features and outcome of chronic lymphocytic leukaemia in Chinese patientsChan, T.S.-Y; Lee, Y.-S; Del Giudice, I; Marinelli, M; Ilari, C; Cafforio, L; Guarini, A; Tan, D; Phipps, C; Goh, Y.T ; Hwang, W ; Goh, A.Z.-K; Siu, L.L.-P; Wu, S; Ha, C.-Y; Lin, S.-Y; Kwok, C.-H; Lau, C.-K; Wong, K.-F; Foà, R; Kwong, Y.-L; Tse, E
312-Aug-2021High-dose methotrexate is effective for prevention of isolated CNS relapse in diffuse large B cell lymphomaOng, Shin Yeu ; de Mel, Sanjay; Grigoropoulos, Nicholas Francis ; Chen, Yunxin ; Tan, Yan Chin; Tan, Melinda Si Yun ; Ng, Lawrence Cheng Kiat ; Lee, Yuh Shan; Phipps, Colin; Goh, Yeow Tee ; Yong, Kar Ying; Liu, Xin; Chng, Wee Joo ; Lim, Soon Thye ; Nagarajan, Chandramouli 
4Jul-2011Multicenter study of comparative outcomes of hematopoietic stem cell transplant for peripheral T cell lymphoma and natural killer/T-cell lymphomaHwang, W.Y.K. ; Piu Koh, L.; Lim, S.-T.; Ching Linn, Y.; Loh, Y.S.; Koh, M.B.C.; Phipps Diong, C.; Jing Lee, J.; Hui Zhang, X.; Rajgor, D. ; Gandhi, M.; Shah, A.; Goh, Y.T. 
52009Outpatient-based therapy of oral fludarabine and subcutaneous alemtuzumab for asian patients with relapsed/refractory chronic lymphocytic leukemiaHwang, W.Y.K. ; Dearden, C.; Loh, Y.S.M.; Linn, Y.C.; Tien, S.L.; Teoh, G.K.H. ; How, G.F. ; Heng, K.K. ; Goh, Y.T. ; Lee, L.H. 
62015Pharmacokinetics and safety of ixazomib plus lenalidomide-dexamethasone in Asian patients with relapsed/refractory myeloma: a phase 1 studyGupta, N; Goh, Y.T ; Min, C.-K; Lee, J.H; Kim, K; Wong, R.S.M; Chim, C.S; Hanley, M.J; Yang, H; Venkatakrishnan, K; Hui, A.-M; Esseltine, D.-L; Chng, W.J 
72014Phase 2 randomized study of bortezomib-melphalan-prednisone with or without siltuximab (anti-IL-6) in multiple myelomaSan-Miguel, J; Bladé, J; Shpilberg, O; Grosicki, S; Maloisel, F; Min, C.-K; Zarzuela, M.P; Robak, T; Prasad, S.V.S.S; Goh, Y.T ; Laubach, J; Spencer, A; Mateos, M.-V; Palumbo, A; Puchalski, T; Reddy, M; Uhlar, C; Qin, X; Van De Velde, H; Xie, H; Orlowski, R.Z
8Feb-2012Single center retrospective analysis of BU-based conditioning regimens in allogeneic transplantationWong, A.M.; Allen, J.C. ; Goh, Y.T. ; Linn, Y.C. ; Loh, S.M.Y.; Diong, C.P.; Chowbay, B.; Hwang, W.Y.K. 
92016Thrombotic microangiopathy during carfilzomib use: case series in SingaporeChen, Y; Ooi, M. ; Lim, S.F; Lin, A; Lee, J; Nagarajan, C; Phipps, C; Lee, Y.S; Grigoropoulos, N.F ; Lao, Z ; Surendran, S; Teh, E.M; Goh, Y.T ; Chng, W.J ; Gopalakrishnan, S.K 
102015Use of Valacyclovir for the treatment of cytomegalovirus antigenemia after hematopoietic stem cell transplantationOng, S.-Y; Truong, H.-T.-T; Diong, C.P; Linn, Y.-C ; Ho, A.Y.-L ; Goh, Y.-T ; Hwang, W.Y.-K 
112018Whole exome sequencing identifies recessive germline mutations in FAM160A1 in familial NK/T cell lymphomaChan, J.Y ; Ng, A.Y.J; Cheng, C.L; Nairismägi, M.-L; Venkatesh, B ; Cheah, D.M.Z; Li, S.-T; Chan, S.H; Ngeow, J ; Laurensia, Y; Lim, J.Q; Pang, J.W.L; Nagarajan, S; Song, T; Chia, B; Tan, J; Huang, D; Goh, Y.T ; Poon, E; Somasundaram, N; Tao, M ; Quek, R.H.H ; Farid, M ; Khor, C.C ; Bei, J.-X; Tan, S.Y ; Lim, S.T ; Ong, C.K; Tang, T